Concepedia

Peter Alping

PA

8

Publications

1.3K

Citations

8

H-Index

2016

Active since

Affiliations

Karolinska Institutet(Current)

University of Gothenburg

Kaiser Permanente

Karolinska University Hospital

Umeå University

Peter Alping is an author at Karolinska Institutet specializing in health policy, epidemiology, and multiple sclerosis.

ORCID

Top concepts

Publications per year

2016–2024

8

Publications

8

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 492 citations · Full text

Rituximab in multiple sclerosis

Jonatan Salzer, Rasmus Svenningsson, Peter Alping et al. · Neurology · 2016 · 340 citations · Full text

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Peter Alping, Thomas Frisell, Lenka Novakova et al. · Annals of Neurology · 2016 · 224 citations

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Peter Alping, Johan Askling, Joachim Burman et al. · Annals of Neurology · 2020 · 130 citations · Full text

Validation of the Swedish Multiple Sclerosis Register

Peter Alping, Fredrik Piehl, Annette Langer‐Gould et al. · Epidemiology · 2018 · 60 citations · Full text

, , +18

Rows per page

1–5 of 8